In this episode, we look at the integration and development of artificial intelligence (AI) into medical technologies, or as the sector is commonly referred to: Medtech.
Countries today are racing to be the global leader in AI. Just earlier this month, President Donald Trump signed the “American A.I. Initiative,” an executive order meant to stimulate the development and regulation of artificial intelligence. Last year in the UK, Prime Minister Theresa May announced a plan to revolutionize how chronic diseases are diagnosed in the country by significantly increasing the use of data and AI.
With AI technology growing ever more sophisticated and governments leaning into its use in healthcare, investment in the sector seems likely to grow. However, there are more reservations about data privacy and concerns over implementation when it comes to incorporating AI in healthcare practices.
So, we turned to healthcare experts to help guide us through the opportunities, challenges, and serious investment opportunity that AI in Medtech presents.
We would like to extend a massive thank you to our amazing guests: Dr. Robert Pearl, author of Washington Post bestseller 'Mistreated'; Dr. Jenny Barnett, Chief Scientific Officer of Cambridge Cognition; and Ariel Beery, CEO of MobileODT.
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
SP Angel research note on commodities and miners, featuring: Centamin (CEY LN) – Q2 Production and exploration update Edenville Energy* (EDL LN) – Start of mining operations at the Northern Area to drive coal run rates up Peak Resources (PEK AU) – Rare earth market update Rio Tinto (RIO LN) – Oyu Tolgoi schedule delayed for additional technical studies Shanta Gold (SHG LN) – Q2 Production keeps Shanta on track to achieve 2019 production guidance Tertiary Minerals* (TYM LN) – Sale of shares in Sunrise Resources